Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Longeveron Inc. (LGVN)


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-10-12 Hare Joshua Chief Scientific Officer Buy 2,500 $3.69 $9,225 No
2021-10-13 Green Geoff CEO Buy 1,000 $3.81 $3,810 No
2021-10-13 Soffer Rock Director Buy 19,900 $3.66 $72,855 No
2021-10-07 Clavijo James CFO and Treasurer Buy 5,000 $3.34 $16,700 No
2021-10-07 Lehr Paul T General Counsel, Secretary Buy 1,750 $3.34 $5,845 No
2021-10-08 Hare Joshua Chief Scientific Officer Buy 5,000 $3.39 $16,930 No
2021-02-12 Hare Joshua Chief Scientific Officer Buy 12,000 $10.00 $120,000 No
2021-02-12 Soffer Rock Director Buy 100 $8.05 $805 No
2021-02-12 Soffer Donald M Director Buy 100,000 $10.00 $1,000,000 No
2021-02-12 Hare Joshua Chief Scientific Officer Buy 103,000 $9.98 $1,028,230 No

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.